# Proof of Concept Study to Assess Safety and Efficacy of Phage Therapy in Hip or Knee Prosthetic Joint Infections Due to Staphylococcus Aureus Treated by DAIR.

> **NCT06605651** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Phagenix** · enrollment: 100 (estimated)

## Conditions studied

- Hip Prosthesis Infection
- Knee Prosthesis Infection

## Interventions

- **BIOLOGICAL:** Anti-Staphylococcus aureus Bacteriophages (PP1493 and PP1815) intra-articular injection with 0.9% NaCl solution
- **DRUG:** 0.9% NaCl solution

## Key facts

- **NCT ID:** NCT06605651
- **Lead sponsor:** Phagenix
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2028-03
- **Final completion:** 2029-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06605651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06605651, "Proof of Concept Study to Assess Safety and Efficacy of Phage Therapy in Hip or Knee Prosthetic Joint Infections Due to Staphylococcus Aureus Treated by DAIR.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06605651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*